#term ID	term description	observed gene count	background gene count	strength	false discovery rate	matching proteins in your network (IDs)	matching proteins in your network (labels)
hsa04514	Cell adhesion molecules	17	138	1.89	5.44e-26	9606.ENSP00000011653,9606.ENSP00000264246,9606.ENSP00000264832,9606.ENSP00000319476,9606.ENSP00000320084,9606.ENSP00000324890,9606.ENSP00000332049,9606.ENSP00000335062,9606.ENSP00000358490,9606.ENSP00000358501,9606.ENSP00000359663,9606.ENSP00000361359,9606.ENSP00000370989,9606.ENSP00000380855,9606.ENSP00000386559,9606.ENSP00000419085,9606.ENSP00000497102	CD4,CD80,ICAM1,ICOS,CD276,CD28,CD86,PDCD1,CD2,CD58,CD40LG,CD40,CD274,PDCD1LG2,CD8A,TIGIT,CTLA4
hsa04660	T cell receptor signaling pathway	11	100	1.84	1.39e-15	9606.ENSP00000011653,9606.ENSP00000226730,9606.ENSP00000229135,9606.ENSP00000319476,9606.ENSP00000324890,9606.ENSP00000335062,9606.ENSP00000359663,9606.ENSP00000386559,9606.ENSP00000398698,9606.ENSP00000412237,9606.ENSP00000497102	CD4,IL2,IFNG,ICOS,CD28,PDCD1,CD40LG,CD8A,TNF,IL10,CTLA4
hsa05330	Allograft rejection	9	34	2.23	1.39e-15	9606.ENSP00000226730,9606.ENSP00000229135,9606.ENSP00000264246,9606.ENSP00000324890,9606.ENSP00000332049,9606.ENSP00000359663,9606.ENSP00000361359,9606.ENSP00000398698,9606.ENSP00000412237	IL2,IFNG,CD80,CD28,CD86,CD40LG,CD40,TNF,IL10
hsa04672	Intestinal immune network for IgA production	8	43	2.07	7.10e-13	9606.ENSP00000226730,9606.ENSP00000264246,9606.ENSP00000319476,9606.ENSP00000324890,9606.ENSP00000332049,9606.ENSP00000359663,9606.ENSP00000361359,9606.ENSP00000412237	IL2,CD80,ICOS,CD28,CD86,CD40LG,CD40,IL10
hsa05320	Autoimmune thyroid disease	8	48	2.02	1.26e-12	9606.ENSP00000226730,9606.ENSP00000264246,9606.ENSP00000324890,9606.ENSP00000332049,9606.ENSP00000359663,9606.ENSP00000361359,9606.ENSP00000412237,9606.ENSP00000497102	IL2,CD80,CD28,CD86,CD40LG,CD40,IL10,CTLA4
hsa05322	Systemic lupus erythematosus	8	94	1.73	1.55e-10	9606.ENSP00000229135,9606.ENSP00000264246,9606.ENSP00000324890,9606.ENSP00000332049,9606.ENSP00000359663,9606.ENSP00000361359,9606.ENSP00000398698,9606.ENSP00000412237	IFNG,CD80,CD28,CD86,CD40LG,CD40,TNF,IL10
hsa04060	Cytokine-cytokine receptor interaction	10	282	1.35	6.99e-10	9606.ENSP00000011653,9606.ENSP00000226730,9606.ENSP00000229135,9606.ENSP00000266557,9606.ENSP00000359663,9606.ENSP00000361359,9606.ENSP00000368538,9606.ENSP00000398698,9606.ENSP00000412237,9606.ENSP00000478699	CD4,IL2,IFNG,CD27,CD40LG,CD40,TNFRSF4,TNF,IL10,TNFRSF9
hsa05332	Graft-versus-host disease	6	36	2.02	1.91e-09	9606.ENSP00000226730,9606.ENSP00000229135,9606.ENSP00000264246,9606.ENSP00000324890,9606.ENSP00000332049,9606.ENSP00000398698	IL2,IFNG,CD80,CD28,CD86,TNF
hsa04940	Type I diabetes mellitus	6	38	2.0	2.27e-09	9606.ENSP00000226730,9606.ENSP00000229135,9606.ENSP00000264246,9606.ENSP00000324890,9606.ENSP00000332049,9606.ENSP00000398698	IL2,IFNG,CD80,CD28,CD86,TNF
hsa05323	Rheumatoid arthritis	7	83	1.73	2.62e-09	9606.ENSP00000229135,9606.ENSP00000264246,9606.ENSP00000264832,9606.ENSP00000324890,9606.ENSP00000332049,9606.ENSP00000398698,9606.ENSP00000497102	IFNG,CD80,ICAM1,CD28,CD86,TNF,CTLA4
hsa05144	Malaria	6	46	1.92	5.32e-09	9606.ENSP00000229135,9606.ENSP00000264832,9606.ENSP00000359663,9606.ENSP00000361359,9606.ENSP00000398698,9606.ENSP00000412237	IFNG,ICAM1,CD40LG,CD40,TNF,IL10
hsa05416	Viral myocarditis	6	55	1.84	1.32e-08	9606.ENSP00000264246,9606.ENSP00000264832,9606.ENSP00000324890,9606.ENSP00000332049,9606.ENSP00000359663,9606.ENSP00000361359	CD80,ICAM1,CD28,CD86,CD40LG,CD40
hsa05340	Primary immunodeficiency	5	37	1.93	1.44e-07	9606.ENSP00000011653,9606.ENSP00000319476,9606.ENSP00000359663,9606.ENSP00000361359,9606.ENSP00000386559	CD4,ICOS,CD40LG,CD40,CD8A
hsa05321	Inflammatory bowel disease	5	59	1.73	1.17e-06	9606.ENSP00000226730,9606.ENSP00000229135,9606.ENSP00000365380,9606.ENSP00000398698,9606.ENSP00000412237	IL2,IFNG,FOXP3,TNF,IL10
hsa04612	Antigen processing and presentation	5	64	1.7	1.60e-06	9606.ENSP00000011653,9606.ENSP00000229135,9606.ENSP00000386559,9606.ENSP00000398698,9606.ENSP00000497910	CD4,IFNG,CD8A,TNF,B2M
hsa05310	Asthma	4	27	1.97	3.20e-06	9606.ENSP00000359663,9606.ENSP00000361359,9606.ENSP00000398698,9606.ENSP00000412237	CD40LG,CD40,TNF,IL10
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	5	87	1.56	6.03e-06	9606.ENSP00000011653,9606.ENSP00000229135,9606.ENSP00000324890,9606.ENSP00000335062,9606.ENSP00000370989	CD4,IFNG,CD28,PDCD1,CD274
hsa05143	African trypanosomiasis	4	36	1.85	8.18e-06	9606.ENSP00000229135,9606.ENSP00000264832,9606.ENSP00000398698,9606.ENSP00000412237	IFNG,ICAM1,TNF,IL10
hsa05145	Toxoplasmosis	5	103	1.49	1.20e-05	9606.ENSP00000229135,9606.ENSP00000359663,9606.ENSP00000361359,9606.ENSP00000398698,9606.ENSP00000412237	IFNG,CD40LG,CD40,TNF,IL10
hsa05166	Human T-cell leukemia virus 1 infection	6	210	1.26	1.58e-05	9606.ENSP00000011653,9606.ENSP00000226730,9606.ENSP00000264832,9606.ENSP00000361359,9606.ENSP00000398698,9606.ENSP00000497910	CD4,IL2,ICAM1,CD40,TNF,B2M
hsa05135	Yersinia infection	5	124	1.41	2.62e-05	9606.ENSP00000011653,9606.ENSP00000226730,9606.ENSP00000386559,9606.ENSP00000398698,9606.ENSP00000412237	CD4,IL2,CD8A,TNF,IL10
hsa04640	Hematopoietic cell lineage	4	90	1.45	0.00020	9606.ENSP00000011653,9606.ENSP00000358490,9606.ENSP00000386559,9606.ENSP00000398698	CD4,CD2,CD8A,TNF
hsa05169	Epstein-Barr virus infection	5	192	1.22	0.00020	9606.ENSP00000264832,9606.ENSP00000358501,9606.ENSP00000361359,9606.ENSP00000398698,9606.ENSP00000497910	ICAM1,CD58,CD40,TNF,B2M
hsa05142	Chagas disease	4	97	1.42	0.00026	9606.ENSP00000226730,9606.ENSP00000229135,9606.ENSP00000398698,9606.ENSP00000412237	IL2,IFNG,TNF,IL10
hsa04064	NF-kappa B signaling pathway	4	101	1.4	0.00027	9606.ENSP00000264832,9606.ENSP00000359663,9606.ENSP00000361359,9606.ENSP00000398698	ICAM1,CD40LG,CD40,TNF
hsa04620	Toll-like receptor signaling pathway	4	100	1.41	0.00027	9606.ENSP00000264246,9606.ENSP00000332049,9606.ENSP00000361359,9606.ENSP00000398698	CD80,CD86,CD40,TNF
hsa04659	Th17 cell differentiation	4	99	1.41	0.00027	9606.ENSP00000011653,9606.ENSP00000226730,9606.ENSP00000229135,9606.ENSP00000365380	CD4,IL2,IFNG,FOXP3
hsa05140	Leishmaniasis	3	69	1.44	0.0023	9606.ENSP00000229135,9606.ENSP00000398698,9606.ENSP00000412237	IFNG,TNF,IL10
hsa04658	Th1 and Th2 cell differentiation	3	85	1.35	0.0041	9606.ENSP00000011653,9606.ENSP00000226730,9606.ENSP00000229135	CD4,IL2,IFNG
hsa04061	Viral protein interaction with cytokine and cytokine receptor	3	96	1.3	0.0056	9606.ENSP00000226730,9606.ENSP00000398698,9606.ENSP00000412237	IL2,TNF,IL10
hsa04625	C-type lectin receptor signaling pathway	3	101	1.28	0.0062	9606.ENSP00000226730,9606.ENSP00000398698,9606.ENSP00000412237	IL2,TNF,IL10
hsa05146	Amoebiasis	3	101	1.28	0.0062	9606.ENSP00000229135,9606.ENSP00000398698,9606.ENSP00000412237	IFNG,TNF,IL10
hsa04650	Natural killer cell mediated cytotoxicity	3	120	1.2	0.0095	9606.ENSP00000229135,9606.ENSP00000264832,9606.ENSP00000398698	IFNG,ICAM1,TNF
hsa05418	Fluid shear stress and atherosclerosis	3	129	1.17	0.0113	9606.ENSP00000229135,9606.ENSP00000264832,9606.ENSP00000398698	IFNG,ICAM1,TNF
hsa04630	JAK-STAT signaling pathway	3	158	1.08	0.0195	9606.ENSP00000226730,9606.ENSP00000229135,9606.ENSP00000412237	IL2,IFNG,IL10
hsa05164	Influenza A	3	163	1.07	0.0206	9606.ENSP00000229135,9606.ENSP00000264832,9606.ENSP00000398698	IFNG,ICAM1,TNF
hsa05152	Tuberculosis	3	165	1.06	0.0208	9606.ENSP00000229135,9606.ENSP00000398698,9606.ENSP00000412237	IFNG,TNF,IL10
hsa05170	Human immunodeficiency virus 1 infection	3	203	0.97	0.0359	9606.ENSP00000011653,9606.ENSP00000398698,9606.ENSP00000497910	CD4,TNF,B2M
